RE: Chelsea9 Oct 2020 23:15
Ruck, ah sneaky over on NEX............(28001). I haven"t traded since we broke past 10p, the 9 out of ten good trades were playing the spread from 6-9p and taking 2 point profits, typically £500 a trade on a £1500 stake. Still trying to get my head round paying £3k for 20k shares if you"re lucky and being new territory just getting into a new range.
Tell you the truth being my first trades on Scancell I was enjoying it very much the extra money came in rather handy but it made each day more interesting as I am sure it does for others. Jst about ready now to starttrading 10/15% of my core holding which worked well for me. I do remeber you saying some time ago that you wouldn"t be adding until we are past 10p, whilst I was buying to get my core to 200k and lowering my average to 13.5p after paying 41p and 38p to get in. I guess it took me so long to be in profit I decided to be more cautious, until now. Wanted to ask a few times the reason for the sequence you use, presumably to differentiate different shares you trade?? No such issues here trading just the one share and after the rise from being 70% down a few months back to 40% up was a great feeling as many of us shared with averages between 12/15p. Hungry for more now and with the newsflow expected IMHOa good time to buy a few.
Apart from COVIDITY, AVIDAMAB, GLYCAN /MABS i still think definitive dates and sites for trials will see another range broken, lol and we get closer to our 50p first target too, something which seemed so far away at 5p, but realistic now. So after 8 long years finally in profit and all platforms seem to be converging together now, an exciting time and one I am enjoying.
Anyway good luck with yours and to everyone here, I have always felt this would be a lucky share for me, tested in the last couple of years but we seem to be on a track now and I keep reminding myself we are on a journey, destination unknown but derisked by the added platforms of which I can see Avidimab producing our first commercial deal, which will change perception to this share no end and add another few million to a warchest which for the first time looks substantial. Wonder how the market will react to that if it is from the first collaboration, with 2 more still running for a few months more.
On that happy note will call it a day, GN
Sign In
Follow the stocks
